article thumbnail

How AI Can Help Medical Science Liaisons Juggle Their Ever-Growing Responsibilities

PM360

Traditionally, Medical Affairs has focused on cross-functional collaboration with commercial and R&D teams, medical communication, evidence generation, and dissemination. 1 And, on average , the FDA approved 60% more drugs between 2010-2019 than the yearly average over the previous decade.

article thumbnail

What A Field Clinical Engineer In Neuromodulation Sales Does With Blake Williams

Evolve Your Success

He provides a fascinating glimpse into what it takes to excel in the field of medical device sales, emphasizing the importance of authenticity and passion. The perfect blend of persistent dedication, a heartwarming touch of southern hospitality, and an innate understanding of the needs of both physicians and patients. I find Dr. B.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Manufacturing challenges set back development progress of cell therapies in oncology

Pharmaceutical Technology

Last year, lifileucel was previously plagued by a different delay, which was an inability to convince the US Food and Drug Administration (FDA) that its potency assays for TILs were robust enough to lead to a uniform product. Only 29% of patients successfully received the CAR-T product within 12 months, and 31.9%

article thumbnail

Bringing Therapies from Bench to Bedside: Navigating Challenges in the Last Mile

Clarify Health

After FDA-approval comes the last critical mile of this journey: bringing the product to market. Successfully launching a new product is no easy feat in the life sciences industry; up to 66% of newly launched drugs fail to meet market expectations within their first year. sales, medical science liaisons, etc.).

article thumbnail

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Medgadget

Currently, the awkwardness of conventional laparoscopic tools keeps many physicians from using them in a variety of cases. Interestingly, due to FDA’s regulatory methodology, surgical robots have to be approved for specific indications by the agency. are still done in an open fashion.

article thumbnail

Change of leadership is needed badly at the FDA and CDC

World of DTC Marketing

We need to follow the science. Physiican trust in the FDA is decling as well. The best way to get accurate health information may be to follow noted physicians on social media. Only 36% express a high level of assurance in the agency, with nearly one-half reporting that their confidence with the FDA has eroded in the past year.

FDA 290
article thumbnail

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Medgadget

To make implantation of the Alpha DaRT sources easy and precise, the company developed dedicated applicators andadapted existing biopsy devices, that physicians are already acquainted with, to deliver the radioactive sources. The FDA looked at the data, saw it promising, and asked for a small feasibility study in the U.S.